NeuroSense Therapeutics

Home
United States
Cambridge, MA
NeuroSense Therapeutics

Biotech company, developing drug for ALS patients
Nasdaq: NRSN

Contact us at: [email protected]

NeuroSense was born with the intent to answer the huge unmet need of patients with amyotrophic lateral sclerosis (ALS) with the understanding that this devastating disease must be addressed from a new perspective. NeuroSense Therapeutics is a clinical-stage drug development company, advancing a groundbreaking treatment for people living with ALS, as well as other neurodegenerative diseases. We are

focused on creating combined therapeutic strategies, targeting the multiple pertinent mechanisms in these complex diseases.

11/06/2025

נוירוסנס ועמותת ישראלס משתפות פעולה כבר שנים במטרה אחת – לשפר את חייהם ועתידם של אנשים המתמודדים עם מחלת ה-ALS.
כחברת ביוטק העוסקת במחקר ופיתוח תרופות למחלה, אנו עדים מדי יום לחשיבות העצומה של התמיכה שמעניקה העמותה לחולים ולבני משפחותיהם - תמיכה שמעניקה כוח, תקווה ומשמעות.
אנחנו מזמינים אתכם להצטרף אלינו, לתרום ולהשתתף באירוע של ישראלס, כדי שיוכלו להמשיך בעשייה המבורכת והחיונית שלהם.

לינק לתרומות - 👇

שני עשורים של תקווה. מתכבדים להזמינכם לאירוע החגיגי השנתי לציון 20 שנות עשייה מבורכת למען קהילת ה-ALS בישראל, שייערך ב-19.11.25 במוזיאון תל אביב לאומנויות. כל ההכנסות יוקדש...

01/22/2025

"It wasn’t until I started working at NeuroSense that I realized how much my life has been affected by ALS. When I was eleven years old, my grandfather passed away from the condition, and this personal experience has been a significant motivator in my professional journey”

Led by a commitment to quality, Yael Barak, our VP of QA, shares the fundamentals of her work and how her personal connection to the cause brings deeper purpose 👇

“It wasn’t until I started working at NeuroSense that I realized how much my life has been affected by ALS. When I was eleven years old, my grandfather passed away from the condition, and this personal experience has been a significant motivator in my professional journey”

01/15/2025

“A close level of engagement and personal touch sets us apart from larger companies, and makes us unique”

Beyond data and protocols, Idan Lushi, our CRA, focuses on the human connection in clinical research. Learn more about his perspective on fostering strong relationships with site staff 👇

“A close level of engagement and personal touch sets us apart from larger companies, and makes us unique”

01/08/2025

“Stay nimble. We are in an ever-changing environment, where one must be able to adapt to thrive. This mindset is key in discovering new opportunities.”

Gain a unique perspective on the fight against ALS - Nedira Salzman-Frenkel, our VP of Business Development, shares her insights on adaptability, collaboration, and navigating the complexities of the pharma industry 👇

“Stay nimble. We are in an ever-changing environment, where one must be able to adapt to thrive. This mindset is key in discovering new opportunities.”

01/02/2025

“It is very refreshing to see so many women at my workplace. As a woman, my day-to-day is easier because I am surrounded by people who understand me as I am.”

Bar Levin, our dedicated office manager, shares her perspective on women in leadership and the empowering environment at NeuroSense Therapeutics.

A must-read for anyone in ! 👇

“It is very refreshing to see so many women at my workplace. As a woman, my day-to-day is easier because I am surrounded by people who understand me as I am.”

12/23/2024

We are honored to share news today on the signing of a binding term sheet with a leading global pharmaceutical company!
Deal terms include:
* A substantial upfront payment upon signing a definitive agreement, in addition to
* Funding for the Phase 3 study
* Regulatory and net sales milestone payments, and -
* A tiered royalty structure with double-digit percentage on annual net sales.
NeuroSense will retain full rights to PrimeC in other key territories.
To read more about the terms click on the link below:

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, announced today that it has entered into a binding term sheet with a leading global pharmaceutical company to advance the develop...

12/16/2024

"If you are not moving forward, you are moving backwards. Standing still means you are moving backwards”

The heart of innovation: How Sharon Vered, NeuroSense's VP of CMC, is transforming PrimeC from concept to reality 💡👇

“If you are not moving forward, you are moving backwards. Standing still means you are moving backwards”

12/10/2024

"What excites me most about working for NeuroSense is the personal connection I have to the mission, and the opportunity to be part of a growing company”

When a personal journey meets a greater mission - Keren Pushett , our Head of HR, shares how NeuroSense Therapeutics intertwines with her family's story 👇

“What excites me most about working for NeuroSense is the personal connection I have to the mission, and the opportunity to be part of a growing company”

12/03/2024

"If you persist and overcome the challenges with which you are faced, you can really change the lives of so many people”

From a Neurologist to Chief Medical Officer at NeuroSense Therapeutics, Dr Ferenc Tracik's journey is a must-read for aspiring and industry leaders 👇

“If you persist and overcome the challenges with which you are faced, you can really change the lives of so many people”

11/25/2024

"What excites me the most is ensuring everything, no matter how many things we have in the air at once, is executed flawlessly"

Imagine the multitasking capabilities of an air traffic controller, only for ALS drug development.

Our COO, Hagit Goclaw-Binder , shares how she masters this complex challenge 👇

“What excites me the most is ensuring everything, no matter how many things we have in the air at once, is executed flawlessly”

11/18/2024

“It is especially important to create strong relationships with all of the people involved in the study to make sure that there is effective collaboration”

Vered Sasson our talented lead CRA, shares her insights on fostering teamwork and meticulousness in clinical studies 👇

“It is especially important to create strong relationships with all of the people involved in the study to make sure that there is effective collaboration.”

11/11/2024

“The feeling of successfully navigating the regulatory landscape and achieving drug approval is indescribable”

Don't miss Diana Shtossel's insights on the complex world of neurodegenerative disease regulations. 👇

“The feeling of successfully navigating the regulatory landscape and achieving drug approval is indescribable”

Address

Cambridge, MA
02142

Website

http://www.neurosense-tx.com/

Alerts

Be the first to know and let us send you an email when NeuroSense Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NeuroSense Therapeutics:

Shortcuts

Want your business to be the top-listed Engineering Company in Cambridge?